Negotiated prices for Kisqali and Verzenio, which the agency said cost Medicare over $1 billion in a year, would become effective starting 2028.

The FDA halted clinical trials of two gene therapies on account of a tumor found in a Hurler syndrome patient who had received RGX-111.

The company, founded by UC Berkeley scientists including Jennifer Doudna, is preparing to test its lead candidate STX-1150 in ...

After a young woman develops mobility and speech issues, her grandmother seeks help from her genetic counselor, who flags a ...

Researchers will evaluate the IL1RAP-targeted nadunolimab with a checkpoint inhibitor in up to 24 metastatic microsatellite stable colorectal cancer patients.

Research conducted by Gustave Roussy will help StarkAge move STX-01, an antibody-drug conjugate targeting senescent cells, toward clinical trials.

The FDA had placed a clinical hold on Phase III trials of nex-z in ATTR-PN and ATTR-CM after a patient experienced a serious adverse event and died.

The US regulator expects to issue a decision on Eisai's application for Leqembi Iqlik, which it has granted priority review, by May 24.

The NHS will collect information from patients about 120 different genetic abnormalities to fast-track access to screening.

The bills would require insurers to cover germline multi-gene testing for inherited cancer risk and imaging with no out-of-pocket cost for patients.